SMMT
Summit Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
SMMT Profile
Summit Therapeutics Inc.
An UK developer of novel medicines for the treatment of Clostridium difficile infection
601 Brickell Key Drive, Suite 1000, Miami, FL 33131
--
Summit Therapeutics Inc., a Delaware corporation (" New Summit "), was incorporated in England and Wales on November 22, 2013 and has become a follow-on issuer to the Company. The Company is a biopharmaceutical company focused on the discovery, development and commercialization of patient, physician, caregiver and socially friendly drug therapies designed to improve quality of life, extend potential lifespan, and address serious unmet medical needs. The company's pipeline of product candidates is designed to be patient-friendly, new-age standard of care in the field of oncology therapy.